NFE2L2 and brain ischemia: A recent study verified that GSK-3β downregulates expression of NRF2 protein and genes downstream of NRF2/ARE in brain ischemia–reperfusion injury [41], suggesting that GSK-3β is a negative regulatory of NRF2 and the associated antioxidant response.